Sertraline and Parnaparin: Interaction Details
AI-assisted, pharmacist-reviewed · AI content regenerated Jul 11, 2026 · Source data updated Jul 2, 2026 · Sources: FDA labeling, DDInter 2.0, cited literature
Sertraline
No brand names on recordParnaparin
No brand names on record
How we grade severity & evidence
Severity levels
- Contraindicated: These should generally not be used together.
- Major: Potentially serious — often needs a change or close monitoring.
- Moderate: Can be significant — usually manageable with monitoring.
- Minor: Usually limited clinical impact.
Evidence grades
- Established: Well documented — supported by controlled studies or strong clinical data.
- Probable: Good supporting evidence, though not definitively proven.
- Suspected: Some evidence suggests this interaction, but it is not well established.
- Possible: Limited or conflicting evidence; the interaction may occur.
- Theoretical: Predicted from the drugs' pharmacology; not yet confirmed in people.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.
You're taking sertraline (an antidepressant) along with parnaparin (a blood thinner given by injection). Both can make bleeding more likely. Sertraline is an SSRI, and these medicines lower the amount of a chemical called serotonin that your platelets use to help form clots. Parnaparin also thins your blood. Together, they add up, so bruises, nosebleeds, or bleeding may happen more easily.
The good news is this is very manageable. Your care team can keep a close eye on you and adjust things if needed. Please don't stop either medicine on your own. Just call your pharmacist or doctor right away if you notice unusual bleeding or bruising.
Effect: Additive increased bleeding risk when sertraline (SSRI) is combined with parnaparin (low-molecular-weight heparin).
Mechanism: SSRIs deplete platelet serotonin, impairing serotonin-mediated platelet aggregation; this pharmacodynamic effect is additive to parnaparin's anticoagulant action on hemostasis. Not a CYP-mediated PK interaction.
- Direction: potentiated bleeding risk (increased effect on hemostasis)
- Onset: delayed
- Evidence: probable (case-control and cohort data)
- Severity: major
Management: Monitor for epistaxis, ecchymosis, hematoma, petechiae, GI or other overt bleeding. Counsel the patient on bleeding signs. Dose and monitoring should be individualized by the care team.
What happens
An increased risk of bleeding
Interaction Deep Dive
If sertraline is administered together with an anticoagulant, watch the patient for indications of heightened bleeding and warn patients about the elevated bleeding risk.1. Platelet-released serotonin plays a key role in preserving hemostasis. Studies using case-control and cohort designs have demonstrated that taking SSRIs (for example, sertraline) alongside anticoagulants is linked to a greater bleeding risk 231. Using sertraline at the same time as an anticoagulant can heighten the likelihood of bleeding. The bleeding events that have been documented include epistaxis, ecchymosis, hematoma, petechiae, and hemorrhages that are life-threatening 1.
Why it happens (mechanism)
Release of serotonin by platelets; additive effects on hemostasis
How to manage this interaction
This combination can be used safely with the right oversight. Here is what typically happens:
- Your care team will watch you more closely for signs of bleeding.
- They may tailor your doses as needed for your situation.
- Keep taking both medicines exactly as prescribed unless your doctor tells you otherwise.
Tell your pharmacist or doctor promptly if you notice nosebleeds, easy bruising, small red spots on the skin, blood in urine or stool, black stools, or bleeding that won't stop. Seek urgent care for severe or uncontrolled bleeding.
Management is individual — confirm any change with your pharmacist or prescriber.
Literature reports
4 reports — tap to read
a) A retrospective cohort study (n=234) reported a heightened risk of clinically relevant bleeding (hospital admission because of bleeding) among patients taking warfarin for atrial fibrillation while also receiving SSRI therapy or within 2 weeks after stopping SSRI therapy. Patients with a mean age of 72 +/- 7 years who received warfarin plus SSRI (n=117) were matched with randomly chosen patients who received warfarin alone (n=117). The SSRIs comprised FLUoxetine, citalopram, PARoxetine, sertraline, fluvoxaMINE, or escitalopram. In the warfarin plus SSRI group, nine patients had 11 bleeding episodes over 213.9 treatment years, while in the warfarin-only group, 10 patients had 14 bleedings over 586.4 treatment years. The respective overall bleeding incidences were 51.4 and 23.9 per 1000 treatment years. Compared with warfarin only, the hazard ratio for first bleedings during warfarin plus SSRI treatment was 3.49 (95% CI; 1.37 to 8.91, p=0.009). The SSRIs involved in patients who bled during concurrent use were sertraline or citalopram. Adding an SSRI was not linked to any change in warfarin dose or INR (p=0.48 and p=0.31 respectively). The study findings may be constrained by prior bleeding events, uncertain patient adherence, and the model's exclusion of clopidogrel, dipyridamol, corticosteroids, and anticoagulants besides warfarin 2.
b) A population-based, case-controlled study of patients newly starting coumarins (acenocoumarol and phenprocoumon) together with selective serotonin reuptake inhibitors (SSRIs) found an elevated risk of hospitalization from non-gastrointestinal bleeding. Drawing on national pharmacy and hospitalization records in the Netherlands, investigators identified 1848 cases admitted for abnormal bleeding and compared them against 5818 control subjects who were likewise taking a coumarin. The median length of treatment in patients was 220 days (range, 1 to 4690 days). Patients receiving SSRIs had a greater risk of hospitalization for non-gastrointestinal bleeding (adjusted odds ratio (OR) 1.7, 95% confidence interval (CI), 1.1 to 2.5); however, the rate of gastrointestinal bleeding (adjusted OR 0.8, 95% CI, 0.4 to 1.5) did not differ significantly 3.
c) In a non-blinded, randomized, placebo-controlled trial with 12 healthy volunteers, the influence of sertraline on the plasma protein binding of warfarin was evaluated. On days and 32 of the study, all participants were given warfarin 0.75 mg/kg. Starting on day 11, each volunteer was randomized to either the sertraline or the placebo group; sertraline was titrated up from 50 mg/day to 200 mg/day. Prothrombin time was recorded before each warfarin dose and at intervals afterward. The investigators determined that sertraline did not enhance the anticoagulant effects of warfarin to a clinically significant degree, even though sertraline was administered at a higher-than-usual dose 4.
d) Case reports and epidemiological studies (case-control and cohort studies) have shown a link between the use of agents that interfere with serotonin reuptake and the occurrence of gastrointestinal bleeding. Based on data from published observational studies, SSRI exposure, especially during the month before delivery, has been associated with a less than 2-fold rise in the risk of postpartum hemorrhage. Bleeding events associated with SSRIs and SNRIs have ranged from ecchymosis, hematoma, epistaxis, and petechiae to life-threatening hemorrhages 1.
Common questions
Can I take Sertraline and Parnaparin together?
Sertraline and parnaparin together add up to a higher bleeding risk, so watch for unusual bruising or bleeding and keep in touch with your care team, who can monitor you and adjust as needed. Do not stop either medicine on your own. Always confirm with your pharmacist or prescriber before making any change.
How serious is the Sertraline and Parnaparin interaction?
It is rated major. Potentially serious — often needs a change or close monitoring.
How quickly could this interaction happen?
The documented onset is "delayed". Effects tend to build up gradually over days to weeks.
How is the Sertraline and Parnaparin interaction managed?
This combination can be used safely with the right oversight. Here is what typically happens: Your care team will watch you more closely for signs of bleeding. They may tailor your doses as needed for your situation. Keep taking both medicines exactly as prescribed unless your doctor tells you otherwise. Tell your pharmacist or doctor promptly if you notice nosebleeds, easy bruising, small red spo… Management is individual — always follow your own care team's guidance.
How strong is the evidence for this interaction?
The evidence is graded "probable". Good supporting evidence, though not definitively proven.
From our Q&A
Real reader questions about these medications, each personally answered by our pharmacist:
Questions for your pharmacist
- Does my dose of Sertraline or Parnaparin need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there a safer alternative to one of these medications for me?
References (4)
- Product Information: ZOLOFT oral tablets, oral solution, sertraline hydrochloride oral tablets, oral solution. Viatris Specialty LLC (per FDA), Morgantown, WV, 2023. DailyMed
- Wallerstedt SM, Gleerup H, Sundstrom A, et al: Risk of clinically relevant bleeding in warfarin-treated patients-influence of SSRI treatment. Pharmacoepidemiol Drug Saf 2009; 18(5):412-416. DOI
- Schalekamp T, Klungel OH, Souverein PC, et al: Increased bleeding risk with concurrent use of selective serotonin reuptake inhibitors and coumarins. Arch Intern Med 2008; 168(2):180-185. PubMed
- Apseloff G, Wilner K, Gerber N, et al: Effect of sertraline on protien binding of warfarin. Clin Pharmacokinet 1997; 32 (suppl. 1):37-42.
Keep reading about Sertraline
Keep reading about Parnaparin
These medications also interact with supplements
Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:
major · moderate · minor — check everything you take with our drug–supplement interaction checker.
Check another combination
Our instant two-drug interaction checker is almost here.
Still have questions about this combination?
Every question gets a real answer from a licensed pharmacist — free, and usually within a day.
Ask the pharmacist